114 related articles for article (PubMed ID: 12931749)
1. Cytotoxicity and apoptosis of ovarian and breast cancer cell lines induced by OVS1 monoclonal antibody and paclitaxel.
Moongkarndi P; Kaslungka S; Kosem N; Junnu S; Jongsomboonkusol S; Theptaranon Y; Neungton N
Asian Pac J Allergy Immunol; 2003 Mar; 21(1):31-41. PubMed ID: 12931749
[TBL] [Abstract][Full Text] [Related]
2. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
Wang Z; Butt K; Wang L; Liu H
Nutr Cancer; 2007; 58(2):230-8. PubMed ID: 17640170
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
4. Establishment of OVS1 and OVS2 monoclonal antibodies recognizing human ovarian mucinous cystadenocarcinoma.
Neungton N; Moongkarndi P; Neungton S; Laohathai K; Srisawat C; Wachirutmanggur L; Thielfoldt R
Asian Pac J Allergy Immunol; 1995 Jun; 13(1):47-53. PubMed ID: 7488344
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel immunoconjugate for the specific treatment of ovarian cancer in vitro.
Jaime J; Pagé M
Anticancer Res; 2001; 21(2A):1119-28. PubMed ID: 11396150
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
Au JL; Li D; Gan Y; Gao X; Johnson AL; Johnston J; Millenbaugh NJ; Jang SH; Kuh HJ; Chen CT; Wientjes MG
Cancer Res; 1998 May; 58(10):2141-8. PubMed ID: 9605758
[TBL] [Abstract][Full Text] [Related]
8. Immuno-histological characterization of OVS1 and OVS2 monoclonal antibodies recognizing human ovarian mucinous cystadenocarcinoma.
Neungton N; Moongkarndi P; Laohathai K; Neungton S; Juntrachotiwit P
Asian Pac J Allergy Immunol; 1992 Dec; 10(2):129-34. PubMed ID: 1284830
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
Ling YH; Yang Y; Tornos C; Singh B; Perez-Soler R
Cancer Res; 1998 Aug; 58(16):3633-40. PubMed ID: 9721872
[TBL] [Abstract][Full Text] [Related]
10. [Induction effect of rapamycin combined paclitaxel on apoptosis of ovarian cancer cell lines A2780 and SKOV3 and the molecular mechanism].
Ma XY; Wang SX; Liu Y; Liu RH; Lu YP; Ma D
Ai Zheng; 2007 Apr; 26(4):367-70. PubMed ID: 17430653
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
12. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
Kim SH; Juhnn YS; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():82-9. PubMed ID: 17404021
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.
Sui M; Chen F; Chen Z; Fan W
Int J Cancer; 2006 Aug; 119(3):712-7. PubMed ID: 16496381
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB
Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
[TBL] [Abstract][Full Text] [Related]
15. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.
Yang YI; Lee KT; Park HJ; Kim TJ; Choi YS; Shih IeM; Choi JH
Carcinogenesis; 2012 Dec; 33(12):2488-98. PubMed ID: 23027625
[TBL] [Abstract][Full Text] [Related]
16. Effects of monoclonal antibodies against human stathmin combined with paclitaxel on proliferation of the QG-56 human lung carcinoma cell line.
Yuan SF; Chen WJ; Zhu LJ; Zheng WE; Chen H; Xiong JP
Asian Pac J Cancer Prev; 2012; 13(6):2967-71. PubMed ID: 22938491
[TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG
Gynecol Oncol; 2010 Jan; 116(1):126-30. PubMed ID: 19875160
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
[TBL] [Abstract][Full Text] [Related]
19. Curcuma zedoaria (Berg.) Rosc. essential oil and paclitaxel synergistically enhance the apoptosis of SKOV3 cells.
Zhou Y; Shen J; Xia L; Wang Y
Mol Med Rep; 2015 Jul; 12(1):1253-7. PubMed ID: 25777341
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells.
Ahn HJ; Kim YS; Kim JU; Han SM; Shin JW; Yang HO
J Cell Biochem; 2004 Apr; 91(5):1043-52. PubMed ID: 15034938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]